HEPHAIST (6433) FY2026 Q3 Earnings Report

Quick View

Executive Summary

The cumulative results for Q3 FY2026 reflected a substantial widening of losses from the operating loss recorded in the same period of the previous year, due to the combination of a significant decline in revenue and increased fixed-cost burdens. Revenue was ¥12.3B (¥17.2B in the previous year, YoY -28.7%), Operating Income was ¥-2.0B (¥-0.5B in the previous year), Ordinary Income was ¥-2.5B (¥-0.6B in the previous year), and Net Income was ¥-2.9B (¥-0.5B in the previous year). In addition to the decline in revenue, a lower gross margin and increased SG&A expenses were the primary causes of the widening losses.

Factors Behind Earnings Fluctuations

【Revenue】Revenue was ¥12.3B, down 28.7% year on year. The Company operates as a single segment (Precision Equipment Manufacturing Business), and contraction in demand or lower shipments has directly translated into a company-wide decline in revenue.

【Profit and Loss】Gross profit was ¥1.65B (¥2.96B in the previous year), down 44.3%, while the gross margin declined by 370bp from 17.1% to 13.4%. SG&A expenses increased 4.8% year on year to ¥3.63B, and the SG&A ratio rose by 940bp from 20.1% to 29.5%. As a result, the operating margin deteriorated from -2.9% to -16.1%, and the operating result was a loss of ¥1.98B (a loss of ¥0.50B in the previous year). After the addition of non-operating expenses of ¥0.63B (including interest expense of ¥0.15B), the ordinary loss was ¥2.48B; including the tax burden, the net loss widened to ¥2.92B. This represents a decline in revenue and earnings (widening losses).

Segment Analysis

The Group operates as a single segment, the Precision Equipment Manufacturing Business, and does not disclose results by segment.

Key Financial Indicators

【Profitability】The operating margin was -16.1% (-2.9% in the previous year), and the net profit margin was -23.8% (-2.9% in the previous year), both representing substantial deterioration. The gross margin was 13.4% (17.1% in the previous year), a decline of 370bp.【Cash Quality】Inventory days were 127 days, DIO was 332 days, and CCC was 358 days, all of which have lengthened, indicating that working capital is tying up funds.【Investment Efficiency】Annualized ROE was -15.5% and annualized ROIC was -9.2%, indicating that invested capital continues to generate losses. Total asset turnover remained low at 0.334x.【Financial Soundness】The equity ratio was 51.3% (56.3% in the previous year), while the current ratio was 224.9% and the quick ratio was 177.4%, indicating that short-term liquidity is secured; however, interest coverage was -12.82x, meaning that interest payments cannot be covered by Operating Income.

Cash Flow Analysis

As the statement of cash flows has not been disclosed, funding trends are assessed based on changes in the balance sheet. Cash and deposits were ¥5.31B, slightly down from ¥5.59B in the same period of the previous year. Work in process increased 19.2% from ¥4.33B to ¥5.16B, and the buildup of inventory amid declining revenue is putting pressure on working capital. Electronically recorded obligations increased 42.8% from ¥1.48B to ¥2.11B, potentially supplementing working capital through the use of extended payment terms. Long-term borrowings declined from ¥6.87B to ¥6.39B, indicating progress in repaying interest-bearing debt; meanwhile, retained earnings decreased by ¥2.98B from ¥13.59B to ¥10.61B due to the recognition of the net loss. Overall, the continued operating losses and inventory accumulation appear to be constraining cash-generation capacity.

Quality of Earnings

The current-period loss includes an extraordinary loss of ¥0.03B (loss on disposal and sale of fixed assets), but the amount is immaterial, and the primary cause of the deterioration in earnings was recurring operating factors. Non-operating income was small at ¥0.12B, while non-operating expenses of ¥0.63B (including interest expense of ¥0.15B) contributed to the widening ordinary loss. Corporate income taxes of ¥0.43B were incurred against a loss before tax of ¥2.49B, and no loss mitigation through tax effects was obtained, resulting in the net loss exceeding the ordinary loss. The increase in work in process (+19.2% year on year) could be converted into future sales; however, the increase in inventory may represent a substantive deterioration factor for operating cash flow. From an accrual perspective, the quality of earnings is assessed as somewhat low.

Earnings Forecast and Guidance

The full-year Company forecast is Revenue of ¥16.0B, Operating Income of ¥-2.2B, Ordinary Income of ¥-3.0B, and an estimated Net Income of approximately ¥-3.4B, calculated from forecast EPS of -¥54.61. The cumulative Q3 progress rate for Revenue is 76.7%, broadly in line with the plan; however, the operating loss has reached 91.7% of the full-year forecast and the net loss has reached 85.9%, indicating that progress on the profit front is weighted toward losses. The allowable operating loss for Q4 is limited to approximately ¥0.18B, and achieving the full-year target presents a high hurdle given the earnings level of the most recent quarter.

Shareholder Returns

Dividends for both the interim and year-end periods were ¥0, and the full-year dividend forecast is also ¥0. Given the cumulative net loss of ¥2.92B and the expected full-year net loss, the payout ratio cannot be calculated (zero dividend). The no-dividend policy is consistent with prioritizing the containment of capital outflows and the preservation of financial flexibility during a loss-making period. No disclosure regarding share repurchases was identified.

Risk Factors

1. Demand and capacity utilization risk: While Revenue declined 28.7% year on year, the Company operates a capital-intensive business in which tangible fixed assets account for 46.0% of total assets; therefore, lower capacity utilization is pressuring profit margins through the under-absorption of fixed costs.

2. Inventory accumulation and cash-constraint risk: DIO of 332 days, inventory days of 127 days, and CCC of 358 days all substantially exceed typical manufacturing-industry benchmarks, increasing the risk of inventory write-downs and cash being tied up during demand fluctuations.

3. Risk of failing to meet the earnings plan: Against a full-year forecast operating loss of ¥2.16B, the cumulative loss is ¥1.98B, representing a progress rate of 91.7%; therefore, limiting losses in Q4 is a prerequisite for achieving the plan.

Industry Benchmark (For Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

Profitability is substantially below the industry median, with both the operating and net profit margins in negative territory.

Growth and Capital Efficiency

The Revenue growth rate is also substantially below the industry median, and the magnitude of the revenue decline is particularly pronounced within the industry.

※Source: Compiled by the Company

Key Points from the Financial Results

1. Revenue declined 28.7% year on year, and the combination of a gross margin of 13.4% (17.1% in the previous year) and an SG&A ratio of 29.5% (20.1% in the previous year) caused the operating margin to deteriorate to -16.1%. Improving profitability will require not only a recovery in Revenue but also a review of the cost and fixed-cost structure.

2. The current ratio of 224.9%, quick ratio of 177.4%, and equity ratio of 51.3% support short-term liquidity; however, interest coverage remains at -12.82x, indicating that interest payments cannot be covered by Operating Income.

3. Inventory has accumulated, particularly work in process, and CCC has reached 358 days. The progress rate against the full-year forecast operating loss is 91.7%, making loss containment in Q4 a prerequisite for achieving the plan.

Theoretical Share Price (Reference Value)

Sensitivity: ¥180–¥190 at a ±1% cost of equity, and ¥180–¥188 at ω±0.1.

Notes:

• As forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
• As net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-08 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting professionals as necessary.

---End of Report---